Background: Traditional lifestyle interventions have shown limited success in improving diabetes-related outcomes. Digital interventions with continuously available support and personalized educational content may offer unique advantages for self-management and glycemic control.

Objective: In this study, we evaluated changes in glycemic control among participants with type 2 diabetes who enrolled in a digital diabetes management program.

Methods: The study employed a single-arm, retrospective design. A total of 950 participants with a hemoglobin A (HbA) baseline value of at least 7.0% enrolled in the Vida Health Diabetes Management Program. The intervention included one-to-one remote sessions with a Vida provider and structured lessons and tools related to diabetes management. HbA was the primary outcome measure. Of the 950 participants, 258 (27.2%) had a follow-up HbA completed at least 90 days from program start. Paired t tests were used to evaluate changes in HbA between baseline and follow-up. Additionally, a cluster-robust multiple regression analysis was employed to evaluate the relationship between high and low program usage and HbA change. A repeated measures analysis of variance was used to evaluate the difference in HbA as a function of the measurement period (ie, pre-Vida enrollment, baseline, and postenrollment follow-up).

Results: We observed a significant reduction in HbA of -0.81 points between baseline (mean 8.68, SD 1.7) and follow-up (mean 7.88, SD 1.46; t=7.71; P<.001). Among participants considered high risk (baseline HbA≥8), there was an average reduction of -1.44 points between baseline (mean 9.73, SD 1.68) and follow-up (mean 8.29, SD 1.64; t=9.14; P<.001). Additionally, average follow-up HbA (mean 7.82, SD 1.41) was significantly lower than pre-enrollment HbA (mean 8.12, SD 1.46; F=22.90; P<.001) There was also significant effect of program usage on HbA change (β=-.60; P<.001) such that high usage was associated with a greater decrease in HbA (mean -1.02, SD 1.60) compared to low usage (mean -.61, SD 1.72).

Conclusions: The present study revealed clinically meaningful improvements in glycemic control among participants enrolled in a digital diabetes management intervention. Higher program usage was associated with greater improvements in HbA. The findings of the present study suggest that a digital health intervention may represent an accessible, scalable, and effective solution to diabetes management and improved HbA. The study was limited by a nonrandomized, observational design and limited postenrollment follow-up data.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209528PMC
http://dx.doi.org/10.2196/28033DOI Listing

Publication Analysis

Top Keywords

diabetes management
12
glycemic control
8
type diabetes
8
950 participants
8
hba baseline
8
hba
7
diabetes
5
improved glycemic
4
control digital
4
digital health
4

Similar Publications

Ureteral stenosis is a frequent complication after kidney transplantation, causing significant morbidity and potential graft function impairment. Treatment options include conservative management, endourological procedures, surgical interventions and percutaneous nephrostomy (PCN). While PCN effectively relieves obstruction, it comes with its own complications.

View Article and Find Full Text PDF

The WOUND-Q is a patient-reported outcome measure for individuals with any type of chronic wound. This study aimed to identify patient and wound factors associated with the four WOUND-Q health-related quality of life (HRQL) scales: Life impact, Psychological, Sleep, and Social. Adults with a chronic wound were recruited internationally through clinical settings between August 2018 and May 2020, and through an online platform (i.

View Article and Find Full Text PDF

New exploration on pathogenesis and early diagnosis of gestational diabetes.

World J Clin Cases

January 2025

Department of Neurology, The Third Affiliated Hospital of Guizhou Medical University, Duyun 558099, Guizhou Province, China.

Gestational diabetes mellitus (GDM) refers to varying degrees of abnormal glucose metabolism that occur during pregnancy and excludes patients previously diagnosed with diabetes. GDM is a unique among the four subtypes of diabetes classified by the international World Health Organization standards. Although GDM patients constitute a small proportion of the total number of diabetes cases, the incidence of GDM has risen significantly over the past decade, posing substantial risk to pregnant women and infants.

View Article and Find Full Text PDF

Objectives: This study was designed to characterize the prevalence, pattern of herbal use, and related factors among diabetic patients in Tabriz, Iran.

Methods: A descriptive cross-sectional study was carried out on 322 diabetic patients with random cluster sampling of specialized and subspecialized clinics in Tabriz, Iran. Binary logistic regression analysis was performed to evaluate the association between predictor variables (sociodemographic and disease-related characteristics and patient preference for treatment type) with herb use Interviews were conducted using a structured questionnaire from October 1, 2022, to April 23, 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!